Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome

Blood (2024) 143 (15): 1496–1512.

https://doi.org/10.1182/blood.2023021671

Published: 2024

Includes: Supplemental data

Journal Articles

Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma

Blood (2023) 141 (2): 180–193.

https://doi.org/10.1182/blood.2022016690

Published: 2023

Includes: Supplemental data

Journal Articles

Safety of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome: Final Results from the Phase 3 Mavoric Study

Youn H. Kim, MD, Martine Bagot, MD PhD, Pier Luigi Zinzani, MD PhD, Madeleine Duvic, MD, Stephen Morris, MBBS, MRCP, FRCR, Ellen Kim, MD, Amy Musiek, MD, Pablo L. Ortiz-Romero, MD PhD, Craig Elmets, MD, Herbert A. Eradat, MDMS, Nina Magnolo, MD, Julia Scarisbrick, MD, Stéphane Dalle, MD PhD, David C. Fisher, MD PhD, Michi Shinohara, MD, Brian Poligone, MD PhD, Barbara Pro, MD, Pietro Quaglino, MD, Nishitha Reddy, MD MSCI, Brigitte Dreno, MD, Larisa J Geskin, MD, Ahmad S Halwani, MD, Amit Khot, MD, Marie Beylot-Barry, MD PhD, Neil Korman, MD, Frederick Lansigan, MD, Steven M. Horwitz, MD, Zanetta S. Lamar, MD, Alison J. Moskowitz, MD, Jillian Wells, MD, Oleg E. Akilov, MD PhD, Dolores Caballero, MD PhD, Richard Cowan, MBBS, MD MRCP, FRCR, Reinhard Dummer, MD, Mary Jo Lechowicz, MD, Francine M. Foss, MD, Lars Iversen, MD, Tomomitsu Miyagaki, MD PhD, Ryan Wilcox, MD, Pierluigi Porcu, MD, Maarten Vermeer, MD PhD, Sunil Abhyankar, MD, Yukihiko Kato, MD PhD, Theresa Pacheco, MD, Shigetoshi Sano, MD PhD, Basem M. William, MRCP,MD, Timothy S. Fenske, MD, Noriko Fukuhara, MD PhD, Koji Habe, MD PhD, Toshihisa Hamada, MD PhD, Eiji Kiyohara, MD PhD, Bryone J. Kuss, MBBS, PhD FRACP, FRCPA, Adam Lerner, MD, Lawrence Mark, MD PhD, Javier Munoz, MD, Hiroyuki Okamoto, MD PhD, Christiane Querfeld, MD PhD, Jiro Uehara, MD, Hisashi Uhara, MD PhD, Kentaro Yonekura, MD PhD, Auris Huen, MD, Kensei Tobinai, MD PhD, Yoshiki Tokura, MD PhD, Erin Boh, MD PhD, Jan Nicolay, MD, Hidefumi Wada, MD, Mollie Leoni, MD, Takahiro Ito, MSc, Fiona Herr, PhD, Lubomir Sokol, MD PhD

Blood (2019) 134 (Supplement_1): 5300.

https://doi.org/10.1182/blood-2019-122778

Published: 2019

Journal Articles

Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma

Blood (2019) 134 (13): 1072–1083.

https://doi.org/10.1182/blood.2018888107

Published: 2019

Includes: Supplemental data

Journal Articles

Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study

Lise M. Lindahl, Søren Besenbacher, Anne H. Rittig, Pamela Celis, Andreas Willerslev-Olsen, Lise M. R. Gjerdrum, Thorbjørn Krejsgaard, Claus Johansen, Thomas Litman, Anders Woetmann, Niels Odum, Lars Iversen

Blood (2018) 131 (7): 759–770.

https://doi.org/10.1182/blood-2017-06-788950

Published: 2018

Includes: Supplemental data

Journal Articles

Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma

Andreas Willerslev-Olsen, Thorbjørn Krejsgaard, Lise M. Lindahl, Ivan V. Litvinov, Simon Fredholm, David L. Petersen, Claudia Nastasi, Robert Gniadecki, Nigel P. Mongan, Denis Sasseville, Mariusz A. Wasik, Charlotte M. Bonefeld, Carsten Geisler, Anders Woetmann, Lars Iversen, Mogens Kilian, Sergei B. Koralov, Niels Odum

Blood (2016) 127 (10): 1287–1296.

https://doi.org/10.1182/blood-2015-08-662353

Published: 2016

Journal Articles

Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation

Thorbjørn Krejsgaard, Andreas Willerslev-Olsen, Lise M. Lindahl, Charlotte M. Bonefeld, Sergei B. Koralov, Carsten Geisler, Mariusz A. Wasik, Robert Gniadecki, Mogens Kilian, Lars Iversen, Anders Woetmann, Niels Odum

Blood (2014) 124 (5): 761–770.

https://doi.org/10.1182/blood-2014-01-551184

Published: 2014

Includes: Supplemental data

Journal Articles

Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma

Youn H. Kim, Madeleine Duvic, Erik Obitz, Robert Gniadecki, Lars Iversen, Anders Österborg, Sean Whittaker, Timothy M. Illidge, Thomas Schwarz, Roland Kaufmann, Kevin Cooper, Kim M. Knudsen, Steen Lisby, Ole Baadsgaard, Susan J. Knox

Blood (2007) 109 (11): 4655–4662.

https://doi.org/10.1182/blood-2006-12-062877

Published: 2007

NARROW

Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome

Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma

Safety of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome: Final Results from the Phase 3 Mavoric Study

Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma

Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study

Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma

Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation

Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only